• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure 2. Increamental cost-effectiveness plane for a 65 year old patient with CAD.

Figure 2Increamental cost-effectiveness plane for a 65 year old patient with CAD

Scatter Plot showing the mean differences in costs and QALYs (based on high intensity –low intensitity statins) illustrates the uncertainity surrounding the estimates of the expected costs and expected effects (QALYs) associated with high intensity compared with low intensity statins

From: Appendix C, Health Economic Modelling

Cover of Lipid Modification
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease [Internet].
NICE Clinical Guidelines, No. 67.
National Collaborating Centre for Primary Care (UK).
Copyright © 2008, Royal College of General Practitioners.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce anypart of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.